A U.S. study published in the journal Science explored the potential of psilocybin, the active compound in magic mushrooms, to alleviate the painful side effects of chemotherapy known as peripheral neuropathy. Researchers tested the substance on rats and human tissue, discovering that psilocybin could protect nerve cells and prevent the development of neuropathy by maintaining mitochondrial function and neural activity. The findings suggest that psilocybin might reduce nerve damage caused by chemotherapy, potentially improving patient outcomes and allowing for more aggressive treatments. However, experts caution that further research is needed to confirm safety and efficacy in humans before clinical applications can begin.
Bias read (Center): The article presents scientific findings without overt ideological framing. While psilocybin is a controversial substance due to its psychoactive properties and legal status, the focus remains on medical research and clinical implications rather than political advocacy. The tone is objective, citing



